Adaptive Glucokinase Activator Systems for High-Risk Diabetes Management
Legal Citation
Summary of the Inventive Concept
This inventive concept adapts glucokinase activators for treating diabetes in renally impaired subjects in specialized scenarios, such as extreme weather conditions, high-security environments, and disaster relief situations.
Background and Problem Solved
The original patent addresses glucokinase-mediated disorders in renally impaired subjects, but lacks consideration for unique operational environments. This inventive concept addresses the specific problem of managing diabetes in high-risk situations, where traditional treatments may be insufficient or impractical.
Detailed Description of the Inventive Concept
The inventive concept encompasses four specialized systems and methods: (1) a wearable-based system for real-time glucose monitoring and healthcare provider communication, (2) a satellite-based emergency medical assistance system for extreme weather conditions, (3) a portable, biometrically authenticated device for high-security environments, and (4) a continuous glucose monitoring and alert system for preventing hypoglycemia. These adaptations ensure the safe and effective treatment of diabetes in renally impaired subjects, even in challenging operational environments.
Novelty and Inventive Step
The new claims introduce novel combinations of glucokinase activators with specialized technologies, such as wearable devices, satellite-based communication systems, biometric authentication, and continuous glucose monitoring. These integrations provide a non-obvious solution for managing diabetes in high-risk situations, distinguishing the inventive concept from the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include integrating glucokinase activators with other specialized technologies, such as artificial intelligence-powered health analytics, telemedicine platforms, or environmental sensors. Variations may also include adapting the inventive concept for other high-risk populations, such as those with cardiovascular disease or chronic obstructive pulmonary disease.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of diabetes management, emergency medical response, and high-security healthcare. Target markets may include healthcare providers, pharmaceutical companies, and medical device manufacturers.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical technology, specifically diabetes management and pharmacological interventions for renally impaired patients, with expertise in glucokinase activator treatments and medical device integration
Person of Ordinary Skill (PHOSITA) Profile
A medical professional with advanced training in endocrinology, pharmaceutical sciences, and medical device engineering, possessing knowledge of diabetes treatment protocols, renal impairment management, and technological healthcare solutions
Obviousness Rationale
A PHOSITA would recognize that extending the source patent's glucokinase activator treatment for renally impaired subjects naturally invites technological augmentation to improve patient monitoring, safety, and treatment delivery. The proposed variations represent predictable technological integrations that solve known challenges in diabetes management, particularly for high-risk patient populations. The technical solutions proposed are logical extensions of existing medical monitoring and communication technologies applied to the established glucokinase activator treatment framework.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,536 |
|---|---|
| Title | Glucokinase activator for treating diabetes with renal impairment |
| Assignee(s) | HUA Medicine (Shanghai) Ltd. |